A new strategy of desensitization in mucopolysaccharidosis type II disease treated with idursulfase therapy: A case report and review of the literature

Mucopolysaccharidosis type II (MPS II) is a multisystemic lysosomal storage disorder caused by deficiency of the iduronate 2-sulfatase enzyme. Currently, enzyme replacement therapy (ERT) with recombinant idursulfase is the main treatment available to decrease morbidity and improve quality of life. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Gragnaniello, Vincenza, Carraro, Silvia, Rubert, Laura, Gueraldi, Daniela, Cazzorla, Chiara, Massa, Pamela, Zanconato, Stefania, Burlina, Alberto B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248226/
https://www.ncbi.nlm.nih.gov/pubmed/35782619
http://dx.doi.org/10.1016/j.ymgmr.2022.100878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248226/
https://www.ncbi.nlm.nih.gov/pubmed/35782619
http://dx.doi.org/10.1016/j.ymgmr.2022.100878

Ejemplares similares